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Abstract
Objective
Previous studies have confirmed Slug as a key player in regulating phenotypic changes
in several cell models, however, its role in smooth muscle cells (SMC) has never been
assessed. The purpose of this study was to evaluate the expression of Slug during
the phenotypic switch of SMC in vitro and throughout the development of vascular
remodeling.
Methods and Results
Slug expression was decreased during both cell-to-cell contact and TGFβ1 induced SMC
differentiation. Tumor necrosis factor-α (TNFα), a known inductor of a proliferative/dedif-
ferentiated SMC phenotype, induces the expression of Slug in SMC. Slug knockdown
blocked TNFα-induced SMC phenotypic change and significantly reduced both SMC pro-
liferation and migration, while its overexpression blocked the TGFβ1-induced SMC differ-
entiation and induced proliferation and migration. Genome-wide transcriptomic analysis
showed that in SMC, Slug knockdown induced changes mainly in genes related to prolif-
eration and migration, indicating that Slug controls these processes in SMC. Notably,
Slug expression was significantly up-regulated in lungs of mice using a model of pulmo-
nary hypertension-related vascular remodeling. Highly remodeled human pulmonary
arteries also showed an increase of Slug expression compared to less remodeled
arteries.
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Conclusions
Slug emerges as a key transcription factor driving SMC towards a proliferative phenotype.
The increased Slug expression observed in vivo in highly remodeled arteries of mice and
human suggests a role of Slug in the pathogenesis of pulmonary vascular diseases.
Introduction
In contrast to other terminally differentiated cells, differentiated/contractile SMC retain high
plasticity and can undergo a phenotypic switch towards a synthetic/dedifferentiated state
under specific stimuli [1]. This feature is common in vascular remodeling-associated diseases
such as pulmonary hypertension (PH), chronic obstructive pulmonary disease (COPD),
artheriosclerosis, aortic aneurysm and post-angioplasty restenosis [1–4], in which dedifferenti-
ated SMC from the media translocate into the intima and proliferate [5–7]. The mechanisms
mediating this phenomenon involve inflammation, shear stress, and hypoxia [4,8,9,10]. Dedif-
ferentiated SMC that become proliferative and migratory, express more extracellular matrix
components and fewer SMC contractile proteins [1,3].
Differentiation of SMC is regulated by transcriptional regulators of the myocardin-related
transcription factor family (MRTF), such as myocardin and myocardin-like proteins 1 and 2
(MLK1 and MLK2) [11]. Myocardin (myoCD) increases the expression of actin cytoskeletal
proteins via serum response factor (SRF). Conversely, SMC phenotypic switch is mediated by
both the loss of positive differentiation signals and by the induction of multiple complemen-
tary repressor pathways, such as Krüppel-like factor 4 (KLF4) and transcription factor Sp1
(SP1) [12]. Interestingly, increased MLK1 expression has been involved in the phenotypic
transition of endothelial cells (EC) in an in vitromodel of endothelial injury [12]; and, SP1
appears to be the main transcriptional regulator of endothelial to mesenchymal transition
(EnMT) in a model of inflammatory bowel disease [13,14], suggesting that transitional
changes in cell phenotype involved in different clinical settings may be regulated by similar
molecular pathways.
Slug belongs to the Snail transcription factor family that is involved in several biological
functions, including epithelial to mesenchymal transition (EMT), cell differentiation, cell
motility, cell cycle regulation, and apoptosis. Slug participates directly in the dissociation of
cell-to-cell contacts by repressing endothelial cadherin (VE-cadherin) gene expression, and
indirectly, by increasing extracellular matrix proteins [15,16]. Recently, the role of Slug in the
control of different transcriptional programs of stem cell differentiation has been highlighted
[17–20]; nevertheless its function in SMC has never been studied.
In the present study, we investigated the role of Slug in the phenotypic switch of SMC and
its potential participation in the development of human pulmonary vascular remodeling. We
showed that Slug induced SMC to undergo a proliferative phenotype by at least, modulating
genes coding for cell proliferation and cell migration related pathways. Interestingly, we found
increased levels of Slug, but not of Snail, in a mouse model of PH-related vascular remodeling
and a positive correlation of Slug expression with the degree of both lung obstruction and arte-
rial wall thickness. In addition, we observed Slug up-regulation in human pulmonary arteries
with high degree of vascular remodeling. To our knowledge, this is the first time that Slug has
been related to SMC proliferation and to vascular remodeling.
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Materials and Methods
Primary cell cultures
Human pulmonary artery SMC were purchased from Lonza (Cologne, Germany). They were
cultured with an appropriate growth medium, which consist in basal medium (SmBM), supple-
mented with growth factors (SingleQuot Kit Supplement; Lonza) and 10% fetal bovine serum
(FBS) (Lonza) as previously performed [20]. All primary cultures were used at passages three
to eight and were maintained in a humidified atmosphere at 37°C in 5% CO2.
Cell models of in vitro differentiation
SMC differentiation was induced by cell-to-cell contact [21]. While cells grown at 70%–80%
confluence (D0) comprised SMC with a dedifferentiated phenotype, cells grown at 100% con-
fluence (D2) exhibited a more differentiated state. And, fully differentiated cells were obtained
4 days after reaching 100% confluence (D6). SMC differentiation under hypoxia was achieved
by plating the cells at D0 or D6 in a hypoxic atmosphere of 1% O2 (New Brunswick™ Galaxy
1
170 R Incubator, Eppendorf, Hamburg, Germany) and harvested after four days of growth.
For in vitro studies with cigarette smoke extract (CSE), 50 ml of basal medium was bubbled
with smoke of four unfiltered cigarettes (3RF, University of Kentucky, Lexington, KY), each
containing 0.7 mg of nicotine and 9 mg of tar according to the manufacturer’s report, through
a syringe-driven apparatus (Protowerx, Vanocuver, Canada). The CSE obtained was filtered
through a 0.22 μm filter (Millipore, Bredfore, MA) and immediately frozen at -80°C until use.
The pH of CSE was between 7.4 and 7.5 when diluted for each experiment. SMC at D6 were
starved by washing three times with serum-free medium and incubated for 8 h to minimize the
effects of FBS. Then, cells were incubated with diluted CSE (1/10) in starved medium for 24 h.
Control cultures were treated with vehicle.
The SMC differentiation phenotype was determined by the relative expression of a smooth
muscle contractile protein profile, which included myoCD, GATA-6, transgelin (sm22α), cal-
ponin and caldesmon, analyzed by real-time PCR (RT-PCR) and the decrease of the stem cell
factor KLF4. The presence of filaments of smooth muscle α-actin (α-SMA), calponin and the
smooth muscle specific myosin heavy chain (SM-MHC) were also assessed by immunofluores-
cence. The proliferative phenotype was evaluated indirectly by the expression of Ki67 by both
RT-PCR and immunofluorescence and directly by cell cycle analysis. To determine cell cycle
progression in SMC during differentiation, flow cytometry analysis was performed (Fortessa,
Becton Dickinson, Franklin Lakes, NJ). Briefly, cells maintained in growth medium were per-
meabilized with ethanol 100% and incubated at -20°C during 30 min. Then, cells were incu-
bated with 10 mg/ml of RNAsa A, and 1 mg/ml of propidium iodide for 30 min in dark at 37°.
We also assessed SMC differentiation in cells maintained at 70–80% confluence (D0) that
were stimulated with transforming growth factor beta 1 (TGFβ1) (10 ng/mL; Acris, Herford,
Germany) [22] for 24 h and 48 h in starved medium (SmBm supplemented with 1% inactive
FBS). In this model, SMC differentiate before achieving 100% confluence. Dedifferentiation of
SMC was induced in 100% confluent (D0) and in fully differentiated cells (D6) by incubation
with the inflammatory cytokine TNFα (10 ng/ml; Bender Medsystems, Vienna, Austria) for 48
h in starved medium.
Senescence experiments
Cellular senescence was evaluated with the Senescence Histochemical Staining Kit (Sigma-
Aldrich, St Louis, MO) following the manufacturer’s guidelines. Dedifferentiated (passage 2)
and fully differentiated SMC (passage 8) were compared to senescent SMC (passage 12).
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Briefly, cells were fixed using formaldehyde solution and incubated with X-gal. Pictures were
taken after an ON incubation at pH 6. Blue senescent cells were counted and expressed as a
percentage of the total number of nuclei DAPI-positive cells.
RNA Isolation and Real Time PCR
Total RNA was isolated using TRIzol1 Reagent (Invitrogen) according to the manufacturer's
instructions. Random-primed cDNA synthesis was performed at 37°C with 1 μg of RNA using
the high capacity cDNA Kit (Applied Biosystems, Foster City, CA). Gene expression was mea-
sured by RT-PCR in a Chromo 4 Real Time PCR detector (Bio-Rad, Hercules, CA) and ABI
fast 7900 HT (Applied Biosystems) using the sensiMix dt kit (Quantace, San Mateo, CA,)
based on the DNA double-strand-specific SYBR green I dye and Taqman probes (Applied Bio-
systems) for detection. The results were normalized to GAPDH and β-actin expression levels
and relative gene expression was analyzed by the 2-ddct method. The primers used and their
sequences are listed in S1 Table.
Western Blotting
SMC were washed with PBS and then lysated with RIPA buffer (50 mM TRIS-Cl, 150 mM
NaCl, 1 mM EDTA, 10% NP-40, 0.10% deoxycholic acid) containing protease inhibitors
(Sigma-Aldrich). The lysate was centrifuged at 14.000g for 15 min at 4°C to pellet debris and
the protein-rich supernatant was stored at -20°C. Total protein concentration was measured
with Bradford (Bio-Rad Laboratories, Hercules, CA). Mixed samples of three experiments per
line containing 60 μg of protein were run in a SDS-PAGE on 5–12% Bis–Tris gel (Biorad)
before transferring to a PVDF membrane. Blocking was done with 5% BSA (Sigma) and sam-
ples were incubated ON with primary antibodies. Primary antibodies against Slug (Cell Signal-
ling, dilution 1/1000), and β-actin (Cell Signalling, dilution 1/1000) were revealed with HRP-
labeled secondary antibody (Upstate, Charlottesville, VA). Blots were exposed with enhanced
chemiluminescence (ECL) (Pierce, Thermo Scientific) and visualized in a LAS 4000 lumi-
Imager (Bio-Rad). Membrane densitometry was analyzed with ImageJ software (Public
domain). Blots were stripped using stripping buffer (50 mM Tris, 20% SDS and 0.7% ß-mer-
captoethanol) and reprobed.
Immunodetection
SMC differentiation was assessed by immunofluorescence using antibodies against α-SMA
(1/750) and calponin (1/75) (DAKO Cytomation, Carpinteria, CA) and SM-MHC (1/250)
(Abcam, Cambridge, UK). An antibody against antigen Ki-67 (1/50) (Novocastra1, Newcastle,
UK) was used to measure cell proliferation. Briefly, cells were washed twice with PBS and fixed
with 4% paraformaldehyde for 30 min. After permeabilization with PBS-0.1% triton, cells were
washed and incubated with the appropriate antibody ON at 4°C. All primary antibodies were
revealed with a secondary antibody conjugated with fluorescein during 90 min (Jackson
Immuno Research, West Grove, PA) at room temperature. Nuclei were stained with DAPI.
Immunofluorescence images were quantified by counting the number of immunoreactive cells
with respect to the number of nuclei.
Wound-healing assay
Forty thousand transfected cells were seeded in 48-well plates with growth medium. After 48 h
of incubation the culture was scratched with a sterile tip and the medium was replaced for
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fresh growth medium. Pictures were taken at baseline and every 12 h. The healing area was
analyzed with Image-Pro Plus software (Media Cybernetics, Inc.)
Knockdown and overexpression experiments
To study Slug overexpression, 1 x 106 cells were transfected with XL6 plasmid and XL6-Slug
using the Amaxa Biosystem (Lonza) following manufacturer’s guidelines. One day after elec-
troporation, cells were cultured with starved medium ON and stimulated with 10 ng/ml of
TGFβ1 (Acris) for 24 h.
Slug knockdown was accomplished with 10nM of siPool against Slug (SiTool Biotech GmBH,
Martinsried), which allows the use of low concentrations of siRNAminimizing off-targets effects
[23]. A scrambled sequence was used as control. Both siPools were transfected using Lipofecta-
mine RNAimax (Invitrogen).
Transcriptome-wide gene expression analysis
SMC were transfected with 10 nM siSlug and mock-transfected in two biological replicates.
RNA was isolated 48 h after transfection and further processed for transcriptome-wide expres-
sion profiles using the Human Gene 2.1 ST array platform (Affymetrix, Santa Clara, CA). Raw
probe set intensities were processed and summarized using the robust multi-chip analysis
(RMA) algorithm [24] with a custom chip definition file (CDF) from Brain array [25]. Expres-
sion was assessed for each gene based on linear modeling of the log2-normalized gene intensi-
ties using the R package Linear Models for Microarray Data [26]. Per-gene log2-fold changes
and Benjamini–Hochberg false discovery rate (FDR)-adjusted p-values were estimated for Slug
knockdown versus control. Slug knockdown samples in our array-based gene expression analy-
sis, determined 355 (1200) genes that were differentially expressed with adjusted p-values of
less than 0.01 (0.05).
In vivo experiments
All procedures involving animals and their care were approved by the Ethics Committee of the
University of Barcelona and the Institutional Committee of the University of Valladolid for
Animal Care and Use. Furthermore, they were conducted according to institutional guidelines
in compliance with national (Generalitat de Catalunya decree 214/1997, DOGC 2450) and
international (Guide for the Care and Use of Laboratory Animals, National Institutes of
Health, 85–23, 1985) laws and policies.
Our mouse model of pulmonary hypertension included 16 female mice (C57/bl6 mice
around 22–25 g) that were divided in three groups. One group was maintained in normoxia
and inoculated with vehicle (control, CTL; n = 6); the second group was exposed to chronic
hypoxia using an initial ramp cycle to reach 10% O2, 5% CO2 for 3 weeks (chronic hypoxia,
CH; n = 5); and the third group was exposed to CH and injected weekly with the VEGFR inhib-
itor, Sugen 5416 (Tocris, R&D Systems, Minneapolis, MN) at 20 mg/Kg (sub/cut) using a 25
gauge needle (CH+SU5416; n = 5) for three weeks. At the end of exposure, right ventricular
pressure (RVP) was determined under anesthesia by inserting a pressure transducer (Milla,
Houston, TX) into the right ventricle via the jugular vein. Animals were then sacrificed and
their lungs processed for histology. The number of intrapulmonary vessels with a diameter
<50 μm showing positive immunostaining for α-SMA were counted and expressed as a per-
centage of the total number of small vessels. The ventricle hypertrophy (Fulton index) was eval-
uated as the ratio between the right ventricle (RV) and left ventricle plus the septum weight.
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Pulmonary artery isolation
Segments of pulmonary artery were obtained from 19 surgical lung specimens that were
resected for the treatment of localized lung carcinoma. The study was approved by the Ethics
Committee of the Hospital Clinic, Barcelona, Spain. Arterial wall morphometry was analyzed
in cross-sectional rings of pulmonary arteries after elastic orcein staining, as previously
described [27]. Pulmonary arteries measuring approximately 2 cm long with an external diam-
eter of 1–2 mm were dissected under microscope and cleaned of surrounding parenchyma and
connective tissue. Segments were preserved in RNAlater1 solution (Ambion, Grand Island,
NY) and frozen at -20°C until RNA extraction using TRIzol1 Reagent (Invitrogen, Grand
island, NY). RNA quality was checked with the LabChip1 Test kit using the Agilent 2100 bioa-
nalyzer (Agilent Technologies, Santa Clara, CA).
Morphometry
The area of the intimal layer, expressed as a percentage of the cross sectional area of the pulmo-
nary artery, was used to classify arteries into 3 groups by establishing the 33 and 66 percentiles
as cut-off values. The different groups were identified as less remodeled (R1), mildly remodeled
(R2) and highly remodeled (R3) pulmonary arteries.
Immunohistochemistry
Slug expression was measured by immunohistochemistry in serial sections of highly remodeled
(n = 3) and non-remodeled pulmonary arteries (n = 5). After hydration of the samples, bovine
serum Albumin was used to block non-specific antibody interactions. The antibodies against
Slug (1/75) (Cell Signaling, Boston, MA,) were added to the samples for 1 h at room tempera-
ture. After two rounds of washing, the secondary antibody was added for 45 min and con-
trasted with hematoxylin stain at room temperature. Areas positive for Slug in the arterial
section were quantified with Image Pro and normalized to the total vessel wall area.
Statistical analysis
All values are reported as mean ± SE. Determinations were performed in duplicate and at least
3 independent experiments were performed for each set of conditions. Two-group compari-
sons were analyzed using the two-tailed paired Student t-test for dependent samples or with
the Mann–Whitney Rank Sum test for non-normally distributed data. Group comparisons
were performed using one-way ANOVA or two-way ANOVA. Post hoc pairwise comparisons
were made using the Student Newman–Keuls test for normally distributed variables or the
Kruskal–Wallis and Dunn test for non-normally distributed variables. For all procedures, P-
values lower than 0.05 were considered statistically significant.
Results
SMC phenotypic change in vitromodels
We analyzed the expression of contractile SMC markers in both cell-to-cell contact and TGFβ1
induced SMC differentiation and during TNFα-induced SMC dedifferentiation. Differentiated
SMC phenotype induced by cell-to-cell contact was associated with higher expression of SMC
contractile markers (myoCD, gata-6, sm22α, calponin and caldesmon) and decreased gene
expression of the stem cell transcription factor KLF4 (Fig 1A). Fully differentiated phenotype
at D6 of culture was also confirmed by the strong expression of α-SMA, calponin and
SM-MHC fibers, determined by immunofluorescence (Fig 1A). Similar results were obtained
when differentiation was induced by 48 h of TGFβ1 treatment (S1 Fig). Ki-67 expression
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Fig 1. In vitromodels of SMC phenotypic change. A, RT-PCR and immunofluorescence of the SMC differentiation
markers (myoCD, sm22α, calponin, caldesmon, GATA6, α-SMA and SM-MHC, and the transcription factor KLF4 at D0,
D2 and D6 states show the acquisition of a mature phenotype in SMC during differentiation. B, Cell proliferation
decreases in differentiated cells, as determined by Ki-67 expression andC, cell cycle analysis.D, RT-PCR of SMC
markers and KLF4 and immunofluorescence of α-SMA, calponin and SM-MHC in TNFα treated SMC showing the
induction of SMC dedifferentiation by this cytokine. E, Gene expression of Ki-67 and F, cell cycle analysis increase
significantly in TNFα treated SMC when compared with controls, indicating greater proliferation. Data are expressed as
the mean ± SEM of five independent experiments performed in duplicate. *p < 0.05 by one-way ANOVA.
doi:10.1371/journal.pone.0159460.g001
Slug and Vascular Remodeling
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(Fig 1B) and the number of cells in S Phase of the cell cycle, measured by flow cytometry (Fig
1C) decreased concomitantly with SMC differentiation indicating that SMC differentiation
was concomitant with the decrease of cell proliferation. No changes in cell senescence were
observed in highly confluent cells compared with proliferative cells (S2 Fig), indicating that
cell senescence is not induced by cell confluence. Dedifferentiation of fully differentiated SMC
was achieved by 48 h of treatment with the inflammatory cytokine TNFα, as shown by the
decrease of contractile genes and an increase of KLF4 expression (Fig 1D). α-SMA, calponin
and SM-MHC fibers also decreased after 48 h of TNFα treatment (Fig 1D). Concordantly,
increased proliferation was observed in TNFα-treated cells, as measured by both higher Ki-67
expression (Fig 1E) and increased cells in the S phase (Fig 1F).
Slug expression correlated with a dedifferentiated phenotype
Wemeasured the expression of Slug and its related transcription factor Snail in these models.
Expression of Slug and Snail were high in proliferative/dedifferentiated SMC (D0) and their
expression decreased significantly to half in fully differentiated SMC (D6) in both cell-to-cell
contact (Fig 2A) and TGFβ1-induced SMC differentiation (S1 Fig). Interestingly, induction of
dedifferentiation by TNFα resulted in the increase of Slug expression but not of Snail expres-
sion (Fig 2B).
Slug regulates proliferation and migration of SMC
In order to investigate whether Slug expression is associated with changes in the proliferative/
migrative phenotype of SMC, gain and loss of function of Slug were performed. Knockdown
of Slug was achieved by using a SiPool against Slug, which resulted in the 90% of Slug knock-
down (S3 Fig). Slug knockdown in highly proliferative cells resulted in a significant decrease in
both Ki-67 expression (Fig 3A) and cells in S phase (Fig 3B). By contrast, Slug overexpression
increased the number of proliferating cells (Fig 3C). These results indicate that Slug expression
sustain SMC proliferation. Migration, measured as the capacity of cells to resolve an in vitro
wound was also measured (Scratch assay). Slug knockdown resulted in the reduction of migrat-
ing cells (Fig 3D), whereas Slug overexpression was associated with an increase in the migra-
tion rate of SMC (Fig 3E), indicating that Slug stimulates a migratory phenotype in SMC.
Fig 2. Slug is upregulated in dedifferentated SMC. A, Slug, and the related transcription factor Snail,
decrease in mature SMC as determined by RT-PCR and western blot analysis. B, RT-PCR and western blot
analyses show increased Slug expression in contractile SMC after 48 h of TNFα treatment. Data are
expressed as the mean ± SEM of five independent experiments performed in duplicate. *p < 0.05 by one-way
ANOVA.
doi:10.1371/journal.pone.0159460.g002
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Fig 3. Slug regulates SMC proliferation andmigration rate. A, RT-PCR and inmunofluorescence analysis
showed that Slug inhibition promoted downregulation of Ki-67 expression, consistent with decreased S
phase of cell cycle analyzed by flow cytometry (B). C, Slug overexpression increases SMC proliferation
analyzed by Ki67 expression. F andG, Cell migration was measured by wound-healing assay and expressed
as the percentage (%) of SMCmigrating/time. Slug knockdown cells display lower migration rates than
control cells (F), while Slug-overexpressing SMC exhibit higher migration rate than control cells (G). Data are
expressed as the mean ± SEM of four independent experiments performed in duplicate. *p < 0.05 by paired t-
test.
doi:10.1371/journal.pone.0159460.g003
Slug and Vascular Remodeling
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Slug regulates both TNF-α and TGFβ1-induced SMC phenotypic
change
We reasoned that if Slug induces proliferation and migration in SMC, it could also regulate
changes in SMC phenotypic switch. Slug knockdown prevented the TNFα-induced dedifferen-
tiation of SMC denoted by the restored expression ofmyoCD, gata-6, calponin and KLF4 fol-
lowing TNFα treatment (Fig 4A). Transient overexpression of Slug disturbed the TGFβ1-
induced SMC differentiation, which resulted in a lower expression of both myoCD and calpo-
nin after 48 h of treatment and a decreased α-SMA and calponin fibers (Fig 4B and 4C).
Slug regulates genes related to cell migration and proliferation in SMC
Differential gene expression analyses using Affymetrix Human Gene 2.1 ST arrays were per-
formed 48 h after Slug knockdown in SMC (Fig 5A and S1 Appendix). GO terms analysis of
Biological Processes that are modified after Slug knockdown revealed that cell proliferation
was one of the most altered pathways. In addition, GSEA analysis showed an enrichment of
downregulated genes related to proliferation (Fig 5B and S3 Table). We validated the up-regu-
lation of the tumor suppressor retinoic acid receptor responder protein 3 (RARRES3, also
known as TIG3) after Slug knockdown (Fig 5C). Furthermore, the decrease of two pro-prolifer-
ative related genes, Cyclin A2 (CCNA2) and Heparin-Binding Epidermal Growth Factor
(HBEGF), after Slug inhibition are shown in Fig 5C. Increased levels of two known Slug targets,
claudin1 (CLDNI) and keratin19 (KRT19) were also validated (Fig 5C). RARRES3, CLDNI
and KRT19 increased along differentiation, whereas CCNA2 and HBEGF decreased (S4 Fig).
These results correlate well with our findings in siSlug-transfected cells.
Slug is increased in mice with severe pulmonary hypertension
Treatment of mice with chronic hypoxia (CH) in combination with the VEGFR inhibitor,
SU5416 (CH+SU5416), reproduces the severe PAH observed in humans. As described previ-
ously [28], muscularization of vessels was increased in both CH and CH+SU5416, with respect
to control mice (Fig 6A). RV hypertrophy was confirmed by the increase in the Fulton Index in
both CH and CH+SU5416 (Fig 6B). Right ventricular pressure (RVP) was increased in animals
exposed to CH or CH+SU5416 (Fig 6C). RT-PCR analysis in lung homogenates showed a
moderate increase of Slug expression in CH and CH+SU5416 animals (Fig 6D). There were no
statistically significant changes in the gene expression of Snail in CH animals compared with
control mice (Fig 6D). A positive correlation was found between Slug expression and both the
number of vessels positive for α-SMA and the Fulton Index (Fig 6E and 6F). Accordingly, in
vitro treatment of SMC for 24 h with CH or cigarette smoke extract (CSE), two well-known
inducers of vascular remodeling, stimulated both the increase of Slug and SMC phenotypic
switch (S5 Fig).
Expression of Slug is enhanced in highly remodeled human pulmonary
arteries
Next, we also tested whether or not Slug expression was altered in human during vascular
remodeling. Seven patients with COPD and eleven subjects with normal lung function (four
non-smokers and seven smokers) were enrolled in our study (S4 Table). Patients with COPD
had significantly lower forced expiratory volume in the first second (FEV1), that is the most fre-
quent index for assessing airway obstruction; lower FEV1/Forced vital capacity (FVC) ratio,
which indicate increased airway resistance to expiratory flow; lower diffusing capacity for car-
bon monoxide (DLCO), which measures the ability of the lungs to transfer gas inhaled air to
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Fig 4. Slug regulates both TNFα-induced dedifferentiation and TGFβ1-induced differentiation. A, The increase of
KLF4 and the decrease of SMCmarker genes induced by TNFα treatment is prevented by Slug knockdown measured by
RT-PCRB-C, TGFβ1-induced increase of SMCmarkers is dampened in Slug overexpressing cells as observed by RT-PCR
(B) and immunofluorescence (C). Data are expressed as mean ± SEM of three independent experiments performed in
duplicate. *p < 0.05 by paired t-test.
doi:10.1371/journal.pone.0159460.g004
Slug and Vascular Remodeling
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the red blood cells in pulmonary capillaries, and mild hypoxemia, than healthy controls.
Groups formed according to their degree of remodeling were matched for subjects with COPD
and subjects with normal lung function; and, there were no differences in respiratory variables
between groups. RT-PCR analysis showed that expression of Slug, but not of Snail, was signifi-
cantly upregulated in highly remodeled pulmonary arteries (R3) compared to less remodeled
arteries (R1) (Fig 7A). Additionally, a positive correlation between Slug gene expression and
Fig 5. Slug regulates genes related to proliferation andmigration pathways. A, Scatter plot of the per-gene log2-fold changes
following Slug knockdown (x-axis). Differentially expressed genes in Slug knockdown cells respect to control are marked in red. Validated
genes are marked in blue. The vertical dashed lines mark the two fold changes.B, Enrichment plot of the GSEA cell cycle. GSEA gave a
normalized enrichment score of -1.621 and an FDR of 0.0, indicating a significant enrichment of downregulated cell cycle-associated
genes.C, Validation of Slug, Snail and other genes array performed by RT-PCR show the downregulation of HBEGF, CCNA2, and the
upregulation of CLDN1, RARRES3 and KRT19. Data are expressed as the mean ± SEM of five independent experiments performed in
duplicate. *p < 0.05 by one-way ANOVA.
doi:10.1371/journal.pone.0159460.g005
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Fig 6. Analysis of Slug expression in the lungs of a mousemodel of severe PAH. A, Partially (within 25–75% visible muscularization)
and totally muscularized (within 75–100% visible muscularization) intrapulmonary vessels with a diameter <50 μm analyzed in CTL: control
group (n = 6), CH: animals exposed to chronic hypoxia (n = 5), CH+SU5416: animals exposed to chronic hypoxia plus Sugen 5416 (n = 5)
show positive immunostaining for α-SMA in CH and CH+SU5416 animals. *p<0.05 by one way ANOVA.B-C, Fulton index (B) and Right
ventricular pressure (RVP) (C) are increased in CH and CHSU5416. D, RT-PCR in lung homogenates showed increased Slug, but not Snail
expression, in the group exposed to CH and CHSU5416 analyzed by one-way ANOVA. E, Correlation between Slug expression (1/dCt)
with both the number of α-SMA positive vessels and F, the Fulton index (note that the lower the 1/dCt, the higher the Slug expression level).
*p < 0.05 by Spearman analysis.
doi:10.1371/journal.pone.0159460.g006
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Fig 7. Analysis of Slug expression in human pulmonary arteries. A, Samples were classified according
to the degree of vascular remodeling: low (R1), mild (R2) and high (R3). Slug but not Snail expression was
significantly increased in R3 arteries compared with R1. *p<0.05 by one way ANOVA.B, Slug expression (1/
dCt) displays a positive correlation with the intimal enlargement of pulmonary arteries measured by % of
intimal thickness of the pulmonary artery (r = 0.44, p<0.05 by Pearson test). Note that the lower the 1/dCt, the
higher the expression level.C, Representative images of Slug immunostaining; Slug expression is
significantly increased in dedifferentiated intimal pulmonary SMC and EC of highly remodeled pulmonary
arteries (right image) compared with less remodeled (left image). Negative control is shown in the first picture.
Slug positive areas were quantified in highly remodeled (n = 3) and less remodeled (n = 4) arteries and
normalized by the total wall area. Highly remodeled pulmonary arteries display a significant increase in Slug
positive cells compared with less remodeled arteries. *p<0.05 by t-test. D, Slug (red), α-SMA (green) and
merged (yellow) immunofluorescence images. Slug expression is predominantly found in the intima layer of
remodeled pulmonary arteries.
doi:10.1371/journal.pone.0159460.g007
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the thickness of the intima layer was found (Fig 7B). Slug localization in cross-sectional artery
rings was assessed by immunohistochemistry and co-immunofluorescence with α-SMA
antibody. Slug was barely detected in the intimal layer of less remodeled arteries (Fig 7C).
In contrast, highly remodeled arteries showed strong intensity in the intima and media layer
(Fig 7D).
Discussion
Although many reports have described key factors involved in the regulation of the SMC phe-
notypic switch [3], the detailed molecular mechanisms driving this process are not yet fully
understood. Furthermore, many of the described players in vitro have not been found to be
associated with vascular disease. In this study, we show that the EMT-related transcription fac-
tor Slug is highly expressed in proliferative SMC, and its expression decreases significantly as
maturity increases. Diminished Slug expression, both during differentiation and after knocking
down its expression, correlated with a reduced proliferation, therefore, suggesting that Slug reg-
ulates the expression of genes related to these pathways. Our genome-wide transcriptome
study revealed that Slug modulates the expression of many genes that regulate proliferation,
which is consistent with cell cycle assays. Specifically, downregulation of Slug in SMC was
related with a decreased expression of both HBEGF and CCNA2, whereas the genes CLDNI,
KRT19 and RARRES3 increased their expression. HBEGF is a stimulator of SMC proliferation
and it is known to play an important role in neointimal formation of a rat model [29]. The
CCNA2 gene encodes for cyclin-A2, a protein involved in cell cycle progression. Nevertheless
Slug is a transcriptional repressor. And, the expression of both the CCNA2 and HBEGF genes
decreased during its knockdown, suggesting that they are indirect targets of Slug. Downregula-
tion of Slug in SMC was related with a greater expression of two known Slug target genes,
CLDNI and KRT19. These genes are involved in adhesion/migration pathways [30,31], which
may explain the increased rate of migration observed following Slug overexpression. Interest-
ingly, both genes are described as specific epithelial genes [30,31]. However, we observed
expression of these genes in differentiated SMC cells and in Slug-knocked down SMC, indicat-
ing that they also play a role in this cell type. Expression of KRT19 has been also previously
described in vascular smooth muscle and skeletal muscle [32,33] RARRES3 is a tumor suppres-
sor [34] gene that maintains cell adhesion and decrease metastasis [35]. Concordantly, its
expression was increased after Slug knockdown. Overall, these results indicate the important
physiological role of Slug in cell proliferation and migration in SMC.
Our study revealed that Slug induces a proliferative/dedifferentiated phenotype in SMC.
This was demonstrated in the Slug overexpression experiments. In these assays, Slug promoted
an increased rate of proliferation and migration and blocked the TGFβ1-induced SMC differ-
entiation. These results agreed with a number of previous works demonstrating the key role of
Slug in regulating cell dedifferentiation, proliferation and migration. Slug upregulation was
found to confer a stem cell-like phenotype in a breast cancer model and in epithelial corneal
cells [36,37]. Recently, it was also shown that Slug blocked differentiation of both striated mus-
cle cells and epidermal cells [17,18]. Slug is a zinc finger transcription factor that suppresses
gene expression through binding to E-boxes in the promoter of its target genes [16, 38]. In
striaded muscle cells, Slug represses differentiation by competing with the bHLH transcription
factor MyoD, which is the main transcription factor driving differentiation of these cells, for
binding to the E-boxes of specific muscle genes [18]. Many smooth muscle-specific genes,
including α-SMA, sm22α and SM-MHC, contain E-boxes in their promoters and are activated
by class I bHLH transcription factors [39]. Also, twist1, a known inductor of EMT, has also
been shown to bind to E-boxes in the promoter region of both sm22α [40] and α-SMA, and
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repress them in vitro and in vivo [40]. In our work, we observed a lack of activation of sm22α
and α-SMA, following Slug knockdown in proliferative cells (S1 Appendix), demonstrating
that Slug is not directly repressing them at this stage of differentiation. However, it cannot be
discarded that Slug displaces bHLH transcriptional activators once these genes are activated in
differentiated cells.
TNFα treatment to induce a phenotypic switch from fully differentiated SMC was used in
this study. Elevated levels of TNFα, or systemic inflammation, have been associated with blood
vessel remodeling [41,42]. Specifically, TNFα is thought to be involved in several chronic hyp-
oxia-associated lung diseases like COPD [43,44]. In our model, TNFα induced Slug but not
Snail up-regulation, and induced contractile protein downregulation in differentiated cells with
a concomitant increase of a migrative/proliferative phenotype. These results correlate well with
previous work where TNFα inhibited the contractile phenotype of cerebral vascular SMC,
inducing pro-inflammatory/matrix-remodeling genes [45], and stimulated Slug expression in
breast cancer cells [46]. We observed that preventing the upregulation of Slug by transfection
of the siSlug, following TNFα treatment, blocked the inflammatory-induced SMC phenotypic
switch. Interestingly, Slug knockdown was able to prevent the TNFα-induced up-regulation of
KLF4, which is a known inductor of SMC dedifferentiation [47]. We also observed increased
Slug, but not Snail expression, in lungs of mice during vascular remodeling and in highly
remodeled human pulmonary artery samples. This interesting asymmetry observed in the
behavior of Slug and Snail has been previously described in several studies. Shirley and col-
leagues described that the two factors are not induced by identical stimuli [48]. In addition,
Slug, but not Snail mRNA was elevated during wound reepithelialization in vitro and, ex vivo
and in vivo in mice [49]. Moreover, to induce EMT, Slug and Snail showed overlapping, as well
as a range of other functions. Slug seems to act early to trigger EMT, whereas Snail acts later to
complete the process [50,51]. Remarkably, Snail knockout mice died at gastrulation [52], while
Slug knockout mice were viable [53]. Altogether, these studies clearly show that Slug and Snail
are not functionally equivalent, although they share certain targets in cell differentiation pro-
cesses. Interestingly, a significant number of Slug overexpressing mice died of cardiac hypertro-
phy and cardiac failure exhibiting the key role of this factor in the cardiovascular system
homeostasis. In correlation with these observations, using a murine model of severe pulmonary
hypertension induced by CH, we found greater expression of Slug in lung homogenates of CH-
exposed animals, as well as a correlation of Slug with the severity of vessel remodeling. These
findings support a stimulating role of Slug in hypoxia-induced SMC proliferation. In correla-
tion, in vitro treatment of SMC with CH or CSE, both of which are reported to regulate cell
proliferation during vascular remodeling [54,55], induced the expression of Slug concomitantly
with cell differentiation defects. Interestingly, we also found a correlation between the intima
thickness of human pulmonary arteries and Slug expression. A recent report from Owens and
colleagues, using a cell-tracing system, showed that more than 80% of medial SMC during
intima hyperplasia in mice undergo phenotypic switch [47]. Also, EnMT, a process in which
both Slug and Snail are involved, was also observed in vivo during the PH-related vascular
remodeling (Fig 8A) [56]. In this work, we documented that highly remodeled arteries showed
a strong intensity of Slug, but not of Snail, in the intima and media layer, indicating that a
greater number of SMC-like cells in the intima could arise from the media through phenotypic
switch of SMC, likely driven by Slug (Fig 8A).
In summary, Slug is revealed as a key transcription factor driving a proliferative/migratory
phenotype of SMC. Our results indicate that in an inflammatory environment, the expression
of Slug is induced in SMC, which in turn, stimulates a SMC proliferative/dedifferentiated phe-
notype, at least through modulating proliferation and migration genes (Fig 8B). To the best of
our knowledge, this is the first time that Slug has been studied during the phenotypic switch of
Slug and Vascular Remodeling
PLOS ONE | DOI:10.1371/journal.pone.0159460 July 21, 2016 16 / 21
SMC. The increased expression of Slug observed in remodeled human pulmonary arteries, sug-
gests that this transcription factor has an important role in the pathogenesis of pulmonary
vascular impairment that is promoted by an inflammatory and/or hypoxic environment.
Accordingly, therapies targeting Slug could be of potential interest in the treatment of pulmo-
nary vascular disorders.
Supporting Information
S1 Appendix. Summary Table of the gene expression in SMC after 48h of Slug knockdown.
(XLSX)
S1 Fig. SMC differentiation model induced by TGFβ1 treatment. A, RT-PCR and B, immu-
nofluorescence of SMC markers show SMC differentiation after 48 h of TGFβ1 treatment. Slug
expression, measured by RT-PCR, decreases in differentiated cells.
(PDF)
Fig 8. Slug induces a proliferative phenotype of SMC. A, Schematic figure showing the contribution of both Slug and Snail to the
phenotypic switch of EC and SMC. Under an inflammatory/hypoxic environment the expression of Slug and Snail increase in EC and
promotes EnMT, while only Slug increases in SMC to induce a proliferative SMC phenotype. B, Schematic figure representing the most
prominent molecular players involved in the phenotypic switch of SMC. In contractile cells, MYCD-SRF/MRTF-SRF complexes bind to
CArG boxes, while bHLH transcription factors, like USF bind to E-boxes to activate and maintain expression of SMC specific markers. In
this stage, Slug is minimally expressed. In consequence, expression of its known targets, like CDN1 and KRT19, as well as the tumor
suppressor RARRES3, are high and migration is repressed. Expression of the cell cycle related genes, CCNA2 and HBEGF, are highly
expressed and the rate of proliferation is very low. Under specific stimuli, such as inflammation and/or hypoxia, the expression of Slug is
triggered. Expression of its target genes CDN1 and KRT19 are blocked and cell migration is activated. Moreover, expression of CCNA2 and
HBEGF decrease and cells become proliferative. In this condition, the expression of the stem cell factor KLF4 is upregulated. Expression of
MYCD and its binding to CArG boxes is also repressed resulting in decreased expression of SMC specific markers. MYCD, myocardin;
SRF, serum response factor; MRTF, myocardin-related transcription factors; KLF4, krüppel like factor 4; CDN1, claudin1; KRT19, keratin
19; RARRES3, retinoic acid receptor related gene 3; CCNA2, cyclinA2; HBEGF, Heparin-Binding EGF-Like Growth Factor.
doi:10.1371/journal.pone.0159460.g008
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S2 Fig. Analysis of cell senescence in the cell-to-cell contact model. Graph showing the per-
centage of senescent cells expressed as b-galactosidase positive cells/total cells. No differences
are observed between D0 and D6 (passage 2–8). Passage 12 is used as a control for cell senes-
cence. p< 0.05 by one-way ANOVA
(PDF)
S3 Fig. Slug siRNA Knockdown efficiency. Representative Slug immunofluorescence, which
demonstrates the decrease of Slug expression around 90% with respect to control cells.
(PDF)
S4 Fig. Gene expression of selected genes from the microarray, during SMC differentiation.
KRT19 (A), RARRES3 (D) and CLDNI (E) increase in differentiated SMC, whereas CCNA2
(C) and HBGEF (B) decrease.
(PDF)
S5 Fig. Analysis of Slug in SMC subjected to hypoxia and CSE. A-B Slug expression increases
in SMC, correlating with SMC dedifferentiation, as shown by the downregulation of SMC
marker genes, in hypoxia-induced cells. C,CSE stimulation promotes the increase of Slug expres-
sion and the decrease of SMC differentiation markers. Data are expressed as the mean ± SEM of
at least three independent experiments performed in duplicate. p< 0.05 by paired t-test.
(PDF)
S1 Table. Primers.
(PDF)
S2 Table. Summary of the top 15 GO terms analysis of Biological pathways.
(PDF)
S3 Table. Summary of the top 30 genes contributing to the enrichment of downregulated
cell cycle genes.
(PDF)
S4 Table. General characteristics of the population.  p<0.005 vs NS. † p<0.005 vs S.
(PDF)
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